SVB Leerink analyst Puneet Souda maintains Hologic (NASDAQ:HOLX) with a Outperform and raises the price target from $85 to $90.
Peloton’s Profitability Potential Is Broadly Underestimated, Says This Analyst
JMP Securities analyst Andrew Boone reiterated a Market Outperform rating on the shares of Peloton Interactive Inc (NASDAQ:PTON) with a price target…